NEW YORK (Reuters Health) – Ceftazidime and amikacin delivered by nebulizer is as effective as intravenous administration in treating ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa, and is…
NEW YORK (Reuters Health) – The combination of etanercept and cyclophosphamide might be a risky one in patients with Wegener’s Granulomatosis, especially with those who have long-term, chronic…
NEW YORK (Reuters Health) – A Phase III trial found that inhaled mannitol helped decrease respiratory symptoms in patients with cystic fibrosis. In the study, published in the…
NEW YORK (Reuters Health) – For patients with work-related asthma, a reduction in exposure to sensitizing agents, rather than complete avoidance, is not likely to improve the condition…
NEW YORK (Reuters Health) – A study from China indicates that vardenafil has favorable effects in patients with pulmonary arterial hypertension (PAH). Dr. Zhi-Cheng Jing, at Tongji University…
NEW YORK (Reuters Health) – When patients with chronic obstructive pulmonary disease (COPD) come down with community-acquired pneumonia, whether or not they use inhaled corticosteroids has no effect…
NEW YORK (Reuters Health) – Bosentan is not an effective therapy for patients with idiopathic pulmonary fibrosis (IPF), suggests a new study organized by the company that makes…
NEW YORK (Reuters Health) – Hydrocortisone therapy may lower the risk of nosocomial pneumonia in severe trauma patients, according to new research from France. The study also found…
NEW YORK (Reuters Health) – Combining electrocardiographic P-axis and QRS duration data can provide enhanced criteria for emphysema detection, researchers report in a February 9th on-line paper in…
NEW YORK (Reuters Health) – Adult patients with asthma exacerbations do as well with 2 days of oral dexamethasone as with 5 days of oral prednisone, according to…